The global Chimeric Antigen Receptor T-cell therapy market is experiencing substantial growth, driven by the growing prevalence of hematological malignancies, advancements in immunotherapy, and supportive regulatory scenerios. The market is segmented by use case, platform, and territory. Key players in the market include pharmaceutical companies, r